Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01)
ArchivedNational Institutes of Health
Description
NIDA grant-funded research programs aiming to develop medications for the treatment of Substance Use Disorders (SUDs) are often hindered by a lack of both human and financial resources. Drug development is a long process that requires teams of people with a wide range of individual skill sets. Consequently, individual grantees with the skills to get through the preclinical stages of drug development often fail to transition their project through the clinic and into the market place. Grantees frequently lack both real world experience of the drug development process and the financial resources to advance a medication to the market place in the necessary timeframe. The purpose of this Funding Opportunity Announcement (FOA) is to help support these efforts to meet these objectives by leveraging the strengths of two or more organizations toward a common goal of medications development.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Contact
NIH OER Webmaster <br/>FBOWebmaster@OD.NIH.GOV <br/>
FBOWebmaster@OD.NIH.GOV
- PostedMar 21, 2012
- ClosesJul 18, 2013
- Award ceiling$2,000,000
- CFDA93.279
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro